Ciprofloxacin Base (86483-48-9)
depictio producti
Ciprofloxacin basis fluoroquinolone idem cum spectro antibacteriali norfloxacino, eiusque actio antibacterial inter fluoroquinolones late usitata validissima est.Praeter altam suam actionem antibacterial contra gram-negativum bacilli, bonum etiam effectum antibacterial in Staphylococcus spp.pauloque minus efficax quam Staphylococcus spp.contra pneumococcum et streptococcum spp.
basi ciprofloxacin adhibetur pro curatione tractus respiratorii infectiones, tractus urinarii infectiones, infectiones tractus intestinalis, Infectiones omnium systematum tractus biliarii, Infectiones intra- abdominis, Infectiones morborum gynecologicorum, ossis et articularium infectiones et graves totius contagio. corpore.
| Tests | Criteria acceptatio | Proventus | |
| Characteres | Fere albus vel pallide luteus cristallinus | Pallida crystallina pulveris | |
| Lepidium sativum | IR : Conforms spectro Ciprofloxacin RS. | Conforms | |
| HPL: Retentionis tempus solutionis maioris partis Sample solutionis Standardi correspondet illa, prout in Assay obtinetur. | |||
| Claritas solutionis | Patet leviter opalescent.(0.25g/10ml Acidum hydrochloricum 0.1N) | Conforms | |
| Damnum in siccitate | ≤1.0% (Arida in vacuo apud 120°C) | 0.29% | |
| Reliqua ignitio | ≤0.1% | 0.02% | |
| Metalla gravis | ≤20ppm | <20ppm | |
| Chromatographic puritas | Ciprofloxacin ethylenedianiine analog | ≤0.2% | 0.07% |
| Fluoroquinolonicacid | ≤0.2% | 0.02% | |
| Alia una immunditia | ≤0.2% | 0.06% | |
| Summa immunditiae | ≤0.5% | 0.19% | |
| (HPLC) Assay | C17H18FN3O3 98.0%~ 102.0% (In fundamento exsiccato) | 100.7% | |
| Conclusio: Conformat USP41 specificationem pro Ciprofloxacin | |||
Related Products
Epistulam tuam hic scribe et mitte nobis
